In world of stem cell research, ‘UC Caucus’ reigns supreme
By David Jensen,
Capitol Weekly
| 06. 21. 2021
They could be called the “UC Caucus,” although that may presume too much. Nonetheless, they come from an institution that has pulled down $1.2 billion from the California state stem cell agency, more than any other enterprise during the last 16 years.
Not to mention that their employer — the University of California — is likely to snag much, much more during the next decade or so.
The “caucus” is composed of the 13 persons with ties to the University of California (UC) who are also members of the governing board of the state’s $12 billion stem cell agency, known officially as the California Institute for Regenerative Medicine(CIRM).
The board is so large, in fact, that at times its board members have outnumbered the CIRM staff.
The UC 13 constitute the largest voting bloc on the CIRM governing board. The “caucus” includes Art Torres, who is a member of the UC Board of Regents and the salaried, vice chairman of the CIRM board of directors. Torres is a well-seasoned, former state politician with decades of vote-counting experience.
The CIRM...
Related Articles
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
By Darren Incorvaia, Fierce Biotech | 03.11.2026
A new method for safely inserting large chunks of DNA into genomes has now measured up in mice, potentially paving the way for the next generation of gene editing medicines.
The approach, which is described in a Nature paper...
By Jason Liebowitz, The New Yorker | 03.06.2026
When Talaya Reid was in high school, in a quiet suburb of Philadelphia, she developed fatigue so severe that she spent afternoons napping instead of going out with friends. She was lethargic at school and her grades suffered, but after...
By Scott Solomon, The MIT Press Reader | 02.12.2026
Chris Mason is a man in a hurry.
“Sometimes walking from the subway to the lab takes too long, so I’ll start running,” he told me over breakfast at a bistro near his home in Brooklyn on a crisp...